Rydex Biotechnology Fund Class H (RYOAX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
50.70
+0.22 (0.44%)
Jun 18, 2025, 4:00 PM EDT
RYOAX Holdings List
As of Apr 30, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | ABBV | AbbVie Inc. | 7.87% |
2 | AMGN | Amgen Inc. | 5.25% |
3 | GILD | Gilead Sciences, Inc. | 4.84% |
4 | VRTX | Vertex Pharmaceuticals Incorporated | 4.44% |
5 | REGN | Regeneron Pharmaceuticals, Inc. | 3.69% |
6 | CTVA | Corteva, Inc. | 3.14% |
7 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.82% |
8 | ONC | BeOne Medicines Ltd. | 2.40% |
9 | AZN | AstraZeneca PLC | 2.18% |
10 | BIIB | Biogen Inc. | 2.04% |
11 | NTRA | Natera, Inc. | 1.99% |
12 | RPRX | Royalty Pharma plc | 1.77% |
13 | UTHR | United Therapeutics Corporation | 1.74% |
14 | INSM | Insmed Incorporated | 1.72% |
15 | BMRN | BioMarin Pharmaceutical Inc. | 1.68% |
16 | ITCI | Intra-Cellular Therapies Inc. | 1.67% |
17 | ILMN | Illumina, Inc. | 1.59% |
18 | NBIX | Neurocrine Biosciences, Inc. | 1.53% |
19 | VTRS | Viatris Inc. | 1.45% |
20 | FGXXX | First American Government Obligations Fund | 1.45% |
21 | EXEL | Exelixis, Inc. | 1.44% |
22 | EXAS | Exact Sciences Corporation | 1.36% |
23 | INCY | Incyte Corporation | 1.34% |
24 | ARGX | argenx SE | 1.32% |
25 | HALO | Halozyme Therapeutics, Inc. | 1.31% |
26 | MRNA | Moderna, Inc. | 1.29% |
27 | ALKS | Alkermes plc | 1.19% |
28 | JAZZ | Jazz Pharmaceuticals plc | 1.17% |
29 | BBIO | BridgeBio Pharma, Inc. | 1.13% |
30 | GH | Guardant Health, Inc. | 1.11% |
31 | TGTX | TG Therapeutics, Inc. | 1.10% |
32 | LEGN | Legend Biotech Corporation | 1.09% |
33 | BPMC | Blueprint Medicines Corporation | 1.09% |
34 | RVMD | Revolution Medicines, Inc. | 1.08% |
35 | BNTX | BioNTech SE | 1.08% |
36 | ADMA | ADMA Biologics, Inc. | 1.00% |
37 | MEDP | Medpace Holdings, Inc. | 0.99% |
38 | CYTK | Cytokinetics, Incorporated | 0.97% |
39 | IONS | Ionis Pharmaceuticals, Inc. | 0.95% |
40 | ROIV | Roivant Sciences Ltd. | 0.94% |
41 | AXSM | Axsome Therapeutics, Inc. | 0.92% |
42 | SRPT | Sarepta Therapeutics, Inc. | 0.91% |
43 | CRSP | CRISPR Therapeutics AG | 0.89% |
44 | PTCT | PTC Therapeutics, Inc. | 0.81% |
45 | RARE | Ultragenyx Pharmaceutical Inc. | 0.79% |
46 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.78% |
47 | SWTX | SpringWorks Therapeutics, Inc. | 0.78% |
48 | RNA | Avidity Biosciences, Inc. | 0.78% |
49 | PTGX | Protagonist Therapeutics, Inc. | 0.73% |
50 | PCVX | Vaxcyte, Inc. | 0.72% |
51 | FOLD | Amicus Therapeutics, Inc. | 0.70% |
52 | VCYT | Veracyte, Inc. | 0.69% |
53 | ACLX | Arcellx, Inc. | 0.68% |
54 | APLS | Apellis Pharmaceuticals, Inc. | 0.67% |
55 | VKTX | Viking Therapeutics, Inc. | 0.67% |
56 | SMMT | Summit Therapeutics Inc. | 0.66% |
57 | ACAD | ACADIA Pharmaceuticals Inc. | 0.66% |
58 | TWST | Twist Bioscience Corporation | 0.65% |
59 | ASND | Ascendis Pharma A/S | 0.63% |
60 | RXRX | Recursion Pharmaceuticals, Inc. | 0.62% |
61 | DNLI | Denali Therapeutics Inc. | 0.57% |
62 | NUVL | Nuvalent, Inc. | 0.57% |
63 | BEAM | Beam Therapeutics Inc. | 0.57% |
64 | DVAX | Dynavax Technologies Corporation | 0.57% |
65 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.56% |
66 | AGIO | Agios Pharmaceuticals, Inc. | 0.55% |
67 | ARWR | Arrowhead Pharmaceuticals, Inc. | 0.54% |
68 | KRYS | Krystal Biotech, Inc. | 0.52% |
69 | IDYA | IDEAYA Biosciences, Inc. | 0.51% |
70 | n/a | J.P. Morgan Securities Llc | 0.50% |
71 | IMVT | Immunovant, Inc. | 0.48% |
72 | CLDX | Celldex Therapeutics, Inc. | 0.45% |
73 | IOVA | Iovance Biotherapeutics, Inc. | 0.45% |
74 | DYN | Dyne Therapeutics, Inc. | 0.43% |
75 | NVAX | Novavax, Inc. | 0.41% |
76 | n/a | Bofa Securities, Inc. | 0.38% |
77 | NTLA | Intellia Therapeutics, Inc. | 0.34% |
78 | GERN | Geron Corporation | 0.29% |
79 | n/a | Other Assets & Liabilities | -1.66% |
As of Apr 30, 2025